Genetech, a member of the Roche Group, had announced that U.S. Food and Drug Administration (FDA) has approved Alecensa (alectinib) for adjuvant treatment of patients with early stage, anaplastiv lymphoma kinase-positive non-small…
Tag: Treatment Options For Lung Cancer
New Deep Learning Tool To Predict Brain Metastasis In Lung Cancer Patients
Lung cancer is the leading cause of deaths from cancers worldwide. Most lung cancers are characterized as non-small cell lung cancer and about 30% of patients progress to advanced stages when it…
Gene Signature to Help Patients with NSCLC
Lung cancer is the leading cause of cancer mortality in the United States and all across the world. Non-small cell lung cancer (NSCLC) accounts for about 80 to 85% of all lung…
SABR For Inoperable Early Stage NSCLC
Stereotactic Ablative Radiotherapy (SABR) is an external beam treatment modality that delivers high precision large doses of radiation. In simple words, it is a way of giving Radiotherapy to precisely target cancer…
Combination Of Radiation And Immunotherapy For Advanced Non-Small Cell Lung Cancer
According to the new study by researchers from the UCLA Health Jonsson Comprehensive Cancer Center, using high doses of radiation with an ablative radiotherapy technique is effective for treatment with locally advanced…
New Study Finds A Way To Stop Key Lung Cancer Spread Protein
Lung cancer is among the most common types of cancers prevailing all over the world. A new study by Tulane University has found a molecular pathway to stop lung cancer spread. The…
Durvalumab for Treatment of Lung Cancer
Durvalumab is a type of immunotherapy and is known by its brand name, Imfinzi. Its role in treatment of small cell lung cancer is increasing. Durvalumab injection is injected into a vein…
Stereotactic Ablative Radiotherapy (SABR) For Lung Cancer
In lung cancer treatment, Stereotactic Ablative Radiotherapy (SABR) is rapidly been used as an important radiation tool. SABR is being evaluated for treatment of medically inoperable lung cancer, operable lung cancers, metastases…